Colorectal cancer circular RNA molecule label and detectableTechnical field
The present invention relates to colorectal cancer molecular marked compound and detectable, be specifically related to colorectal cancer circular RNA molecule markNote thing and detectable.
Background technology
Colorectal cancer sickness rate in recent years has obvious ascendant trend, and the post-operative survival rates situation of the patient of colorectal cancer hasBigger improvement, but the five of colorectal cancer patients years overall survival are the highest, and one factor of most important of which is exactly,Diagnosed in colorectal cancer patients the most timely in disease pathogenetic early stage and treated.Now it is used for diagnosing digestive system attacked by pestiferous factorsProperty tumor method mainly include digestive endoscopy inspection, imaging examination, biochemical and immunologic test and gene diagnosis.ImmunologyCheck that the label of colorectal cancer mainly has CA19-9, CEA, P53, K-ras etc., but limited to the value of early diagnosis.ThereforeIf Authorization Notice No. is the patent of invention of CN103740854R, disclose colorectal cancer label CystatinSN,The detectable of CystatinS and CystatinSA albumen, the detectable of this cystatin may be used forThe differential expression of the early diagnosis of colorectal cancer, cancerous issue and cancer beside organism is clearly.But colorectal cancer mark molecule at presentNote thing is substantially research and the application of albumen aspect, and its immunology detection means are loaded down with trivial details, waste time and energy, and cost is high, and benefit is low,And result is the most notable.The annular RNA(circRNA of gene aspect) it is the special non-coding RNA of the class recently confirmed, it is RNAThe conservative product of the class stabilizer pole formed after montage, circRNA can as miRNA sponge affect the regulation and control of gene withExpress, interacted by the miRNA with disease association, disease plays important regulating and controlling effect.Research worker is had to send outExisting circRNA plays very in the disease generating processes such as atherosclerosis, nerve problems, diabetes and tumorImportant effect.At present, studied confirmation circRNA and there is significant difference at the expression of gastric cancer and non-cancer tissue, be to faceThere is on bed the new biomarkers of potential diagnostic value.But at present, the most do not disclose any about utilizationCircRNA molecule checks the correlational study report of colorectal cancer as the molecular marker that detection colorectal cancer is predicted or diagnosedRoad.
Summary of the invention
The technical problem to be solved is to provide a kind of colorectal cancer circular RNA molecule label and detection examinationAgent, this circular RNA molecule label is hsa_circ_002146, and its detectable has detection the most quickly, simple and convenient,Advantage with strong points.
The present invention solves the technical scheme that above-mentioned technical problem used: colorectal cancer circular RNA molecule label, shouldCircular RNA molecule label is hsa_circ_002146.
The detectable of this colorectal cancer circular RNA molecule label is a pair specific primer, and this is to specific primerNucleotide sequence as follows:
The nucleotides sequence of forward primer is classified as: 5 '-TGAAGAGCAT TCCAGATC-3 ',
The nucleotides sequence of downstream primer is classified as: 5 '-TCCTTCCTAC ACCCTACT-3 '.
Compared with prior art, it is an advantage of the current invention that colorectal cancer circular RNA molecule label and detectable, shouldCircular RNA molecule label is that hsa_circ_002146, hsa_circ_002146RNA are significantly lower than by cancer in colorectal cancerTissue, can be as the molecular marked compound of colorectal cancer；The detectable of this molecular marked compound is a pair specific primer:TGAAGAGCAT TCCAGATC and TCCTTCCTAC ACCCTACT, this detectable can go out colorectal cancer with specific detectionHsa_circ_002146RNA is significantly lower than cancer beside organism, if hsa_circ_002146 genetic fragment low expression level, and expressMultiple be less than 0.545, then it is assumed that colorectal cancer, this gene detection reagent have special, sensitive, quick and detect simple and convenient,Advantage with strong points.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is described in further detail.
Embodiment 1
Colorectal cancer circular RNA molecule label, this circular RNA molecule label is hsa_circ_002146, beCircBase data base (http://circbase.org/cgi-bin/simplesearch.cgi) obtains hsa_circ_002146RNA sequence, and utilize bioinformatics method analysis and a large amount of case research to obtain its phase close with colorectal cancerClosing, the expression in colorectal cancer is significantly lower than normal structure.The detectable of this colorectal cancer circular RNA molecule label is oneTo specific primer: 5 '-TGAAGAGCAT TCCAGATC-3 ' and 5 '-TCCTTCCTAC ACCCTACT-3 ', this is to drawingThing is by circular rna hsa_circ_002146 being cyclized the research in site, analyzing and design primer, and by testing,Screening finally obtains this and is synthesized primer, primer by Shanghai Sheng Gong biological engineering limited company.
Embodiment 2
The pair of primers utilizing embodiment 1 carries out case detection, and concrete detection process is as follows:
1, DNA extraction: we gather 5 example colorectal cancer flesh tissue sample and correspondences from Li Huili Hospital, Ningbo City Medical CenterCancer beside organism's sample, use TRIZOL reagent (Invitrogen Life Technologies Co, USA) according to explanationBook extract total tissue RNA, by NanoDrop2000 ultramicrospectrophotometer (Thermo Fisher Scientific,USA) concentration and the purity of gained RNA are detected, then by total serum IgE GoScript Reverse Transcription (RT)System test kit (being purchased from Promega company of the U.S.) reverse transcription to specifications becomes cDNA, cDNA to dilute 4 times with without enzyme waterObtain cDNA sample.
2, PCR reaction: take 4ul cDNA sample solution and join 10ul Roche lightCycler 480 SYBRIn GREEN I Master mixed liquor (being purchased from Roche company of the U.S.), add 1.6 ul specificity upstream and downstream primers (upper and lowerTrip primer concentration is all 10pmol/ul), 4.4ul, without RNase water, forms 20 ul reaction systems at sieve RocheLightCycler 480 II instrument enterprising performing PCR amplified reaction；Amplification step include initial activation at 94 DEG C, 10 minutes；94℃20 s, 55 DEG C of 30 s, 72 DEG C of 30 s, carry out the annealing reaction of 45 circulations altogether；It is 95 DEG C of 1min after having reacted, 59 DEG C30s, 95 DEG C of 30s enter melting curve analysis, it is judged that the specificity of product.
3, after PCR primer order-checking, after result comparison for the purpose of fragment, this purpose fragment comprises hsa_circ_002146 cyclisation site, for hsa_circ_002146 specific fragment.Use 2-△△CTMethod carries out finishing analysis knot to dataFruit finds: detected patient RNA hsa_circ_002146 in colorectal cancer with under pairing normal tissue expression differenceAdjust, if hsa_circ_002146 genetic fragment low expression level, and express multiple less than 0.545(replacement specificity upstream and downstreamThe reference gene GAPDH of primer expands forward primer sequence: 5 '-AGTAGAGGCAGGGATGATG-3 ', reverse primer sequences:5 '-TGGTATCGTGGAAGGACTC-3 ', are purchased from the raw merit in Shanghai, and detection method is ibid), then it is assumed that colorectal cancer, as table 1 is tied directlySignificant difference is there is in intestinal cancer cancerous issue with the hsa_circ_002146RNA expression of cancer beside organism.
Table 1: cancerous issue gene and hsa_circ_002146RNA relative expression's comparison sheet of cancer beside organism
| Name | Disease | Cancerous issue hsa_circ_002146 is expressed | Cancer beside organism hsa_circ_002146 expresses |
| Ma Guicai | Colon cancer | 0.3413 | 2.3221 |
| Xu Yuxing | Colon cancer | 0.1962 | 1.5652 |
| Li Guanghuai | Colon cancer | 0.1263 | 1.8895 |
| Fang Song | Colon cancer | 0.5368 | 1.5892 |
| Li Liping | Colon cancer | 0.3541 | 2.5895 |
From table 1 it follows that in colorectal cancer condition subject, examined by the detectable of hsa_circ_002146RNASurveying, the hsa_circ_002146RNA of its cancerous issue expresses the hsa_circ_002146RNA table significantly lower than cancer beside organismReach.
<110>Zhou Chongchang
<120>colorectal cancer circular RNA molecule label and detectable
<160> 2
<170> PatentIn version 3.1
<210>1
<211> 18
<212> RNA
<213>artificial sequence
<220>
<223>the forward primer sequence of colorectal cancer circular RNA molecule label is expanded
<400>1
TGAAGAGCAT TCCAGATC 18
<210>2
<211> 18
<212>RNA
<213>the downstream primer sequence of colorectal cancer circular RNA molecule label is expanded
<400>2
TCCTTCCTAC ACCCTACT 18